RCKT: Utang marang Ekuitas rocketpharma.com

Logo perusahaan publik Rocket Pharmaceuticals, Inc. (RCKT)

The daily price chart for the total debt-to-equity ratio of Rocket Pharmaceuticals (RCKT) is 0.07. The business relies on external contractors for testing and production, focusing instead on research. Its competitive advantage is driven by unique patents in the field of rare blood and heart pathology therapies. The development of new drugs is accelerated through collaboration with academic centers and specialized clinics.

RCKT: Total Utang marang Modal Rocket Pharmaceuticals, Inc. 04.07.2022 - 29.10.2026

Rincian metrik lan analitis perusahaan Rocket Corp (RCKT)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Rocket Pharmaceuticals, Inc.|RCKT - Prakiraan gabungan firma investasi
- informasi kapitalisasi pasar:
Nilai pasar Rocket Pharmaceuticals|RCKT - Nilai Bisnis
- rincian nilai buku perusahaan:
Nilai Buku saben Saham Rocket Pharmaceuticals|RCKT - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku rocketpharma.com|RCKT - Nilai Agregat Aset
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Rocket Pharmaceuticals|RCKT - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Rocket Pharmaceuticals|RCKT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Rocket Pharmaceuticals|RCKT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rocket Pharmaceuticals|Indikator likuiditas cepet rocketpharma.com
- informasi bathi lan kelipatan valuasi:
RCKT - Bathi sawise mbayar pajeg
Analisis komprehensif perusahaan:RCKT, Rocket Pharmaceuticals, Inc.
Barang utama Rocket Corp

Diversifying the supply of biocomponents for gene therapy ensures operational cycle stability for Rocket Pharmaceuticals (RCKT). Reliable logistics reduce the need for emergency borrowings, which directly impacts the leverage ratio. This coefficient is calculated as the ratio of total liabilities to the company's net assets. It determines the business's degree of dependence on external financing and its solvency risks. By analyzing the company's leverage history, an investor can assess the resilience of the balance sheet.

Pesaing utama

TEM (tempus.com) - Total Utang marang Modal|Rasio Utang marang Ekuitas QGEN (Qiagen NV)|Utang marang Ekuitas Ionis Pharma (IONS)|Repligen Inc. - Rasio Utang marang Ekuitas|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi RARE (Ultragenyx Pharmaceutical Inc.)|Beam Therapeutics Corp (BEAM) - Utang marang Ekuitas|Utang marang Modal Sarepta Corp (SRPT)|TWST (Twist Bioscience) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas 10xgenomics.com (TXG)|Utang marang Ekuitas Intellia Therapeutics, Inc. (NTLA)|Total Utang marang Modal Stoke Therapeutics Inc (STOK)|Total Utang marang Modal BLFS (BioLife Corp)|Wave Pharma (WVE) - Utang marang Modal|MAZE: Rasio Total Utang marang Ekuitas|sionnatx.com - Utang Agregat marang Modal|PRME (Prime Medicine) - Rasio Total Utang marang Ekuitas|Taysha Gene Therapies Inc - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas uniQure Corp|MeiraGTx Corp - Utang Agregat marang Ekuitas|Total Utang marang Modal RGNX|SLDB (solidbio.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal OCGN (Ocugen)|Total Utang marang Modal Pacific Biosciences of California, Inc. PACB|BNTC - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi DSGN (Design Corp)|4D Molecular Therapeutics (FDMT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Lexeo Therapeutics, Inc.|KRRO (Korro Bio Inc.) - Total Utang marang Modal|Total Utang marang Modal Editas Medicine Inc|Total Utang marang Modal SLN|Rasio Total Utang marang Ekuitas proqr.com PRQR|Total Utang marang Modal CDXS (Codexis)|sangamo.com (SGMO) - Utang marang Modal|NAUT: Rasio Total Utang marang Ekuitas|MGX - Total Utang marang Modal|DTIL (Precision BioSciences, Inc.) - Rasio Total Utang marang Ekuitas|GBIO: Utang Agregat marang Modal|BOLD (Boundless Bio, Inc.) - Total Utang marang Modal|Exicure Corp (XCUR) - Koefisien Total Utang marang Modal|Total Utang marang Modal IMNN|Rasio Total Utang marang Ekuitas phiopharma.com PHIO|Total Utang marang Modal MBIO (Mustang Bio)|Total Utang marang Modal TransCode Therapeutics Inc. RNAZ|BNGO - Utang marang Ekuitas|APDN: Utang marang Ekuitas|bluebird bio (BLUE) - Utang marang Ekuitas|IPA - Koefisien Total Utang marang Modal|Utang marang Ekuitas Omega|OMIC: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal RGLS|Rasio Total Utang marang Ekuitas syros.com SYRS|Utang marang Ekuitas Telesis Bio TBIO|Total Utang marang Modal TRACON Pharmaceuticals Inc. TCON|UBX: Rasio Total Utang marang Ekuitas